-
Stopping smoking before the age of 40 avoids more than 90% of the excess mortality caused by smoking in women.
-
I just had a patient present for consultation, concerned hed transmitted herpes simplex virus (HSV) to two new sexual partners, despite a lack of symptoms or obvious lesions, and expressing concern about the adequacy of suppressive acyclovir therapy. He had tried to convince both new partners it was not him! I had to disappoint him.
-
A second factor XA inhibitor (novel oral anticoagulant, NOAC), after rivaroxaban, has been approved for prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF). Apixaban is marketed by Bristol-Myers Squibb and Pfizer as Eliquis.
-
Among men diagnosed with prostate cancer, those with the highest levels of plasma omega-3 fatty acids demonstrated an increased risk for developing prostate cancer, bringing into question various recommendations for increased omega-3 intake.
-
Elderly patients with mild-to-moderate depressive symptoms may experience improvement in affect with the practice of mindfulness-based stress reduction.
-
Osteoarthritis (OA) can be described as the failed repair of damage that has been caused by excessive mechanical stress (defined as force/unit area) on joint tissues.1 This implies that although multiple factors may lead to OA, mechanical impact (either as a major single event or as repetitive micro trauma) is central to all of these, and that the sequence of events that ensues represents the intrinsic repair process, which may either fail or be successful in restoring joint function. Also known as osteoarthrosis or degenerative joint disease, OA is the most important chronic musculoskeletal disorder in both humans and horses.
-
In a large, international observational study, patients who had repair of flail mitral valve leaflets within 3 months of diagnosis had better long-term survival and a lower risk of heart failure than those managed with watchful waiting.
-
A new serotonin and norepinephrine reuptake inhibitor (SNRI) has been approved by the FDA for the treatment of major depressive disorder (MDD).
-
Long-term Mortality Among Adults with Asthma; Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes; New Hope for Hepatitis C Patients
-
